Protein Kinases Type II (PKG II) Combined with L-Arginine Significantly Ameliorated Xenograft Tumor Development: Is L-Arginine a Potential Alternative in PKG II Activation?

BACKGROUND: The mammalian cyclic guanosine monophosphate (cGMP)-dependent protein kinases type II (PKG II) plays critical physiological or pathological functions in different tissues. However, the biological effects of PKG II are dependent on cGMP. Published data indicated that L-arginine (L-Arg) pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yan, Liu, Ying, Cai, Zhensheng, Qin, Huijuan, Li, Hongfan, Su, Wenbin, Wang, Ying, Qian, Hai, Jiang, Lu, Wu, Min, Pang, Ji, Chen, Yongchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2018
Materias:
Animal Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810367/
https://www.ncbi.nlm.nih.gov/pubmed/29401205
http://dx.doi.org/10.12659/MSM.906213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810367/
https://www.ncbi.nlm.nih.gov/pubmed/29401205
http://dx.doi.org/10.12659/MSM.906213

Ejemplares similares